KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) Gross Margin (2016 - 2025)

Exact Sciences (EXAS) has disclosed Gross Margin for 16 consecutive years, with 70.11% as the latest value for Q4 2025.

  • On a quarterly basis, Gross Margin rose 106.0% to 70.11% in Q4 2025 year-over-year; TTM through Dec 2025 was 69.69%, a 14.0% increase, with the full-year FY2025 number at 69.69%, up 14.0% from a year prior.
  • Gross Margin was 70.11% for Q4 2025 at Exact Sciences, up from 68.64% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 95.38% in Q4 2022 to a low of 52.28% in Q1 2022.
  • A 5-year average of 69.79% and a median of 69.93% in 2021 define the central range for Gross Margin.
  • Peak YoY movement for Gross Margin: soared 2051bps in 2022, then crashed -2521bps in 2023.
  • Exact Sciences' Gross Margin stood at 74.87% in 2021, then increased by 27bps to 95.38% in 2022, then decreased by -26bps to 70.17% in 2023, then dropped by -2bps to 69.05% in 2024, then grew by 2bps to 70.11% in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Gross Margin are 70.11% (Q4 2025), 68.64% (Q3 2025), and 69.35% (Q2 2025).